| Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat. | |
| | |
MedLine Citation:
|
PMID: 19593209 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Calcium-sensing receptors (CaSRs) have been localized in the juxtaglomerular apparatus where they may contribute to the regulation of renin release. In the present study, we investigated the in-vitro and in-vivo effects of the calcimimetic R-568 on renin release. METHODS: In vitro, the effect of calcimimetics on renin release was assessed by incubating freshly isolated rat juxtaglomerular cells with or without R-568 (1 and 10 mumol/l) in serum-free medium in the presence or absence of forskolin or CaCl2. In vivo, we measured the impact of R-568 (20 ng/min intravenously) on the acute changes in plasma renin activity (PRA) induced by either a 90 min infusion of the angiotensin-converting enzyme inhibitor captopril, or the beta-receptor agonist isoproterenol, or of a vehicle in or after a furosemide challenge in conscious Wistar rats. RESULTS: In vitro, R-568 dose-dependently blunted renin release, but also reduced the increase in renin due to forskolin (P < 0.01). Both isoproterenol and enalapril increased in vivo PRA to 3.1 +/- 0.3 and 3.7 +/- 0.5 ng Ang I/ml per h, respectively (P < 0.01), compared with vehicle (1.5 +/- 0.2 ng Ang I/ml per h). R-568 significantly reduced PRA to 2.1 +/- 0.1 ng/ml per h in isoproterenol-treated rats and to 1.6 +/- 0.2 ng/ml per h in enalapril-treated rats (P < 0.05). In low-salt treated animals, acute infusion of furosemide increased PRA from 8.7 +/- 3.2 to 18.6 +/- 2.3, whereas R-568 partially blunted this rise to 11.2 +/- 1.5 (P = 0.02). In vivo, R-568 significantly lowered serum calcium and PTH1-84, but the drug-induced changes in PRA were independent of the changes in calcium and parathyroid hormone. CONCLUSION: After the recent discovery of CaSRs in juxtaglomerular cells of mice, our results confirm the presence of such receptors in rats and demonstrate that these receptors modulate renin release both in vitro and in vivo. This suggests that CaSRs play a role as a regulatory pathway of renin release. |
| | |
Authors:
|
Marc P Maillard; Andr??e Tedjani; Christine Perregaux; Michel Burnier |
Related Documents
:
|
14871039 - Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy. 10695969 - Investigation of the haemodynamic effects of phoneutria nigriventer venom in anaestheti... 7378239 - Half-life of angiotensin ii in the conscious and barbiturate-anaesthetized rat. 1592469 - Increased vascular angiotensin formation in female rats harboring the mouse ren-2 gene. 1618259 - Drinking induced by subcutaneous injection of angiotensin ii in the rat is blocked by t... 18158339 - Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical ... 12163719 - Lumbar nerve root injury induces central nervous system neuroimmune activation and neur... 6161669 - The effect of intravenous aprotinin (trasylol) on intraperitoneal adhesion formation in... 11388689 - Prior exposure to methylenedioxyamphetamine (mda) induces serotonergic loss and changes... |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of hypertension Volume: 27 ISSN: 1473-5598 ISO Abbreviation: J. Hypertens. Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-11-09 Completed Date: 2010-01-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8306882 Medline TA: J Hypertens Country: England |
Other Details:
|
Languages: eng Pagination: 1980-7 Citation Subset: IM |
Affiliation:
|
Division of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland. marc.maillard@chuv.ch |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
pharmacology Angiotensin-Converting Enzyme Inhibitors / pharmacology Aniline Compounds / pharmacology* Animals Calcium Chloride / pharmacology Captopril / pharmacology Cells, Cultured Forskolin / pharmacology Isoproterenol / pharmacology Juxtaglomerular Apparatus / cytology, drug effects, metabolism* Male Rats Rats, Wistar Receptors, Calcium-Sensing / agonists*, metabolism* Renin / metabolism* Renin-Angiotensin System / drug effects, physiology* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Aniline Compounds; 0/N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine; 0/Receptors, Calcium-Sensing; 10043-52-4/Calcium Chloride; 62571-86-2/Captopril; 66428-89-5/Forskolin; 7683-59-2/Isoproterenol; EC 3.4.23.15/Renin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
Next Document: Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acce...